Literature DB >> 6821656

Fate of senescent megakaryocytes in the bone marrow.

J M Radley, C J Haller.   

Abstract

Degenerating senescent megakaryocytes have been identified in mouse bone marrow by light and electron microscopy. The ultrastructural changes which occur as degeneration proceeds are characteristic of death by apoptosis, although most cells appear to round up rather than undergo fragmentation. A hitherto unreported finding in degenerating cells was the presence of bundles of approximately 7 nm diameter parallel filaments in nuclei and membrane-bound nuclear fragments. Structurally, they resembled bundles of filaments induced in nuclei with dimethyl sulphoxide and identified as actin. Often a bundle appeared to terminate at the inner membrane. In the cytoplasm the presence of microtubules and centrioles indicates that not all the latter organelles are lost by the megakaryocyte during platelet release. Degenerating senescent megakaryocytes are rare in the marrow of normal mice but increase in frequency during 5-fluorouracil stimulated thrombocytosis. The dying cells are eventually phagocytosed by macrophages, a process that can occur extravascularly, showing that entry of senescent megakaryocytes into the circulation is not necessary for their disposal.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6821656     DOI: 10.1111/j.1365-2141.1983.tb02022.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  16 in total

Review 1.  In vivo platelet production from mature megakaryocytes: does platelet release occur via proplatelets?

Authors:  Goro Kosaki
Journal:  Int J Hematol       Date:  2005-04       Impact factor: 2.490

Review 2.  The biogenesis of platelets from megakaryocyte proplatelets.

Authors:  Sunita R Patel; John H Hartwig; Joseph E Italiano
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

3.  Mechanisms of organelle transport and capture along proplatelets during platelet production.

Authors:  Jennifer L Richardson; Ramesh A Shivdasani; Chad Boers; John H Hartwig; Joseph E Italiano
Journal:  Blood       Date:  2005-08-23       Impact factor: 22.113

Review 4.  Historical review: megakaryopoiesis and thrombopoiesis.

Authors:  Kenneth Kaushansky
Journal:  Blood       Date:  2008-02-01       Impact factor: 22.113

5.  Ultrastructure of multinucleated giant cell apoptosis in foreign-body granuloma.

Authors:  T Honma; T Hamasaki
Journal:  Virchows Arch       Date:  1996-06       Impact factor: 4.064

6.  Improved quantitative analysis of primary bone marrow megakaryocytes utilizing imaging flow cytometry.

Authors:  Lisa M Niswander; Kathleen E McGrath; John C Kennedy; James Palis
Journal:  Cytometry A       Date:  2014-01-16       Impact factor: 4.355

7.  Induction of platelet formation from megakaryocytoid cells by nitric oxide.

Authors:  E Battinelli; S R Willoughby; T Foxall; C R Valeri; J Loscalzo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-04       Impact factor: 11.205

8.  Macrophages in normal human bone marrow and in chronic myeloproliferative disorders: an immunohistochemical and morphometric study by a new monoclonal antibody (PG-M1) on trephine biopsies.

Authors:  J Thiele; C Braeckel; S Wagner; B Falini; D Dienemann; H Stein; R Fischer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

9.  Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) impairs the regulation of apoptosis in megakaryocytes by activating NF-κB: a proteomic study.

Authors:  Michela Di Michele; Karen Peeters; Serena Loyen; Chantel Thys; Etienne Waelkens; Lutgart Overbergh; Marc Hoylaerts; Christel Van Geet; Kathleen Freson
Journal:  Mol Cell Proteomics       Date:  2011-10-04       Impact factor: 5.911

10.  SDF-1 dynamically mediates megakaryocyte niche occupancy and thrombopoiesis at steady state and following radiation injury.

Authors:  Lisa M Niswander; Katherine H Fegan; Paul D Kingsley; Kathleen E McGrath; James Palis
Journal:  Blood       Date:  2014-04-15       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.